These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24827975)

  • 1. Design of novel urogenital pharmabiotic formulations containing lactobacilli, salivaricin CRL 1328 and non-microbial compounds with different functionalities.
    Vera Pingitore E; Juárez Tomás MS; Wiese B; Nader-Macías ME
    Drug Dev Ind Pharm; 2015 Jun; 41(6):942-52. PubMed ID: 24827975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lyophilization and storage temperature on the activity of salivaricin CRL 1328, a potential bioactive ingredient of a urogenital probiotic product.
    Vera Pingitore E; Bru E; Elena Nader-Macías MI
    J Gen Appl Microbiol; 2012; 58(2):71-81. PubMed ID: 22688238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina.
    Vera Pingitore E; Hébert EM; Nader-Macías ME; Sesma F
    Res Microbiol; 2009; 160(6):401-8. PubMed ID: 19591924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli.
    Zárate G; Tomás MS; Nader-Macias ME
    Can J Microbiol; 2005 Jun; 51(6):483-9. PubMed ID: 16121226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations.
    Juárez Tomás MS; De Gregorio PR; Leccese Terraf MC; Nader-Macías ME
    Eur J Pharm Sci; 2015 Nov; 79():87-95. PubMed ID: 26299342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances.
    Corcoran BM; Ross RP; Fitzgerald GF; Stanton C
    J Appl Microbiol; 2004; 96(5):1024-39. PubMed ID: 15078519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vitamins and osmolites on growth and bacteriocin production by Lactobacillus salivarius CRL 1328 in a chemically defined medium.
    Vera Pingitore E; Hebert EM; Sesma F; Nader-Macías ME
    Can J Microbiol; 2009 Mar; 55(3):304-10. PubMed ID: 19370073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics.
    Broeckx G; Vandenheuvel D; Claes IJ; Lebeer S; Kiekens F
    Int J Pharm; 2016 May; 505(1-2):303-18. PubMed ID: 27050865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Steps towards the Pharmaceutical Development of Ovules Containing Lactobacillus Strains: Viability and Antimicrobial Activity as Basic First Parameters in Vaginal Formulations.
    Camilletti AL; Ruíz FO; Pascual LM; Barberis IL
    AAPS PharmSciTech; 2018 Feb; 19(2):886-895. PubMed ID: 29043604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial immunomodulatory and antibiofilm triple effect of Salivaricin LHM against Pseudomonas aeruginosa urinary tract infection model.
    Mahdi LH; Jabbar HS; Auda IG
    Int J Biol Macromol; 2019 Aug; 134():1132-1144. PubMed ID: 31136751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir.
    Bolla PA; Serradell Mde L; de Urraza PJ; De Antoni GL
    J Dairy Res; 2011 Feb; 78(1):15-22. PubMed ID: 20822567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial lactobacilli: effects on the vaginal tract in a murine experimental model.
    De Gregorio PR; Juárez Tomás MS; Santos V; Nader-Macías ME
    Antonie Van Leeuwenhoek; 2012 Nov; 102(4):569-80. PubMed ID: 22638932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model.
    Zárate G; Santos V; Nader-Macias ME
    Infect Dis Obstet Gynecol; 2009; 2009():48358. PubMed ID: 17485818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and beneficial properties of lactic acid bacteria from raniculture subjected to freeze-drying and storage.
    Montel Mendoza G; Pasteris SE; Otero MC; Fatima Nader-Macías ME
    J Appl Microbiol; 2014 Jan; 116(1):157-66. PubMed ID: 24118924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a beneficial product for newborn calves by combining Lactobacilli, minerals, and vitamins.
    Maldonado NC; Silva de Ruiz C; Nader-Macías ME
    Prep Biochem Biotechnol; 2016 Oct; 46(7):648-56. PubMed ID: 26675304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.
    Broeckx G; Vandenheuvel D; Henkens T; Kiekens S; van den Broek MFL; Lebeer S; Kiekens F
    Int J Pharm; 2017 Dec; 534(1-2):35-41. PubMed ID: 28986319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of freeze-dried vaginal Lactobacillus strains in the presence of different lyoprotectors.
    Juárez Tomás MS; Bru E; Martos G; Nader-Macías ME
    Can J Microbiol; 2009 May; 55(5):544-52. PubMed ID: 19483783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.
    Corr SC; Li Y; Riedel CU; O'Toole PW; Hill C; Gahan CG
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7617-21. PubMed ID: 17456596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.
    Barrett E; Hayes M; O'Connor P; Gardiner G; Fitzgerald GF; Stanton C; Ross RP; Hill C
    Appl Environ Microbiol; 2007 Jun; 73(11):3719-23. PubMed ID: 17416691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.